Ratings De Rucci Healthy Sleep Co., Ltd.

Equities

001323

CNE100005DN1

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-07 pm EDT			5-day change	1st Jan Change
35.17 ^CNY	+0.03%		+1.79%	+15.31%

Apr. 26	De Rucci Healthy Sleep Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 01	Tranche Update on De Rucci Healthy Sleep Co., Ltd.'s Equity Buyback Plan announced on September 6, 2023.	CI

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 50% by 2026.
The group's high margin levels account for strong profits.
Analysts covering this company mostly recommend stock overweighting or purchase.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Home Furnishings

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
DE RUCCI HEALTHY SLEEP CO., LTD.	+15.31%	1.95B		-
TEMPUR SEALY INTERNATIONAL, INC.	+1.92%	9.04B		B
JASON FURNITURE (HANGZHOU) CO.,LTD.	0.00%	4.02B		C-
SUOFEIYA HOME COLLECTION CO., LTD.	+12.85%	2.41B		C
LA-Z-BOY INCORPORATED	-7.57%	1.45B		B-
MOTOMOTION CHINA CORPORATION	+43.40%	1.23B		-
SHEELA FOAM LIMITED	-27.21%	1.17B		C+
XILINMEN FURNITURE CO.,LTD	+12.99%	1.03B		-
HENGLIN HOME FURNISHINGS CO.,LTD	+6.71%	900M		-
YOTRIO GROUP CO., LTD.	-9.54%	839M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes